RS Oncology

Q: What is RS Oncology's official website?

RS Oncology's official website is www.rsoncology.com

Q: What is RS Oncology's Revenue?

RS Oncology's revenue is <$5 Million

Q: What industry does RS Oncology belong to?

RS Oncology is in the industry of: Manufacturing , Pharmaceuticals , Business Services

Q: What is RS Oncology competition?

RS Oncology top competitors include: Tempest Therapeutics , Bolt Biotherapeutics , Revitope Oncology , The Column Group

Q: What technology does RS Oncology use?

Some of the popular technologies that RS Oncology uses are: WordPress.org, PHP, Cloudflare Website Optimization, Sentry

Q: What does RS Oncology do?

RS Oncology is a clinical-stage biotech focused on developing innovative PRX3-targeting therapies to combat oxidative-stress-dependent cancers, including mesothelioma and metastatic diseases. The company aims to provide new treatment options for patients with aggressive cancers that have limited therapies available. Their team of experts is current... ly evaluating RSO-021 in a Phase 2 clinical trial for various cancer types, including metastatic breast and ovarian cancers. RS Oncology is dedicated to improving survival chances for patients and their families through novel scientific mechanisms. Read More

Q: What are RS Oncology social media links?

RS Oncology Linkedin page RS Oncology Twitter page RS Oncology Facebook page

Q: Is RS Oncology a public company?

RS Oncology is private company therefore does not currently have an official ticker symbol

Manufacturing · Massachusetts, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

1 Broadway Ste 14, Cambridge, Massachuse...

Website

www.rsoncology.com

Revenue

<$5 Million

Industry

Manufacturing

Pharmaceuticals

Business Services

Research & Development

About RS Oncology

RS Oncology is a clinical-stage biotech focused on developing innovative PRX3-targeting therapies to combat oxidative-stress-dependent cancers, including mesothelioma and metastatic diseases. The company aims to provide new treatment options for patients with aggressive cancers that have limited therapies available. Their team of experts is currently evaluating RSO-021 in a Phase 2 clinical trial for various cancer types, including metastatic breast and ovarian cancers. RS Oncology is dedicated to improving survival chances for patients and their families through novel scientific mechanisms.Explore more

Is this data correct?

View contact profiles from RS Oncology

SIC Code 28,283NAICS Code 32,325Show more

RS Oncology Org Chart

Jarrett Duncan

Chief Executive Officer

Phone

Brian Cunniff

Chief Science Officer

Phone

Get the full picture

Compare Similar Companies to RS Oncology

Compare insights from companies similar to RS Oncology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.